Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of reagent for promoting miR-21 expression in preparation of medicine for preventing and/or treating diabetic keratopathy

A technology of mir-21 and 1.mir-21, which is applied in the field of medicines and reagents to promote the expression of miR-21, can solve the problems of unclear effect and mechanism of diabetic keratopathy.

Pending Publication Date: 2021-11-05
山东第一医科大学附属青岛眼科医院
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In vitro studies have also reported that miR-21 can regulate the expression of the target gene PTEN, thereby reducing the apoptosis of Schwann cells, which may be one of the key mechanisms for miR-21 to play a protective role in peripheral nerve injury repair, but miR- The role and mechanism of 21 in the occurrence and development of diabetic keratopathy are still unclear

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of reagent for promoting miR-21 expression in preparation of medicine for preventing and/or treating diabetic keratopathy
  • Application of reagent for promoting miR-21 expression in preparation of medicine for preventing and/or treating diabetic keratopathy
  • Application of reagent for promoting miR-21 expression in preparation of medicine for preventing and/or treating diabetic keratopathy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] Establishment of type I diabetes mouse model:

[0055] 1) Male C57 mice aged 6-8 weeks were used, and they were routinely fed for one week after purchase, and the body weight and blood glucose of each mouse were recorded before injection; WT and miR-21KO male mice were also fed until 6-8 weeks to induce the model.

[0056] 2) The mice to be intraperitoneally injected with STZ were fasted for 12 hours.

[0057] 3) Prepare the current STZ-citrate solution, the final concentration is 7.5mg / mL, calculate the injection volume according to the dose of 60mg / kg per mouse, and use 1 ml insulin injection for intraperitoneal injection of mice, pay attention to the injection process It should be protected from light, put in food after the injection, replace the drinking water with 5% glucose, and replace it with normal water before fasting.

[0058] 4) Control mice of the same age were only injected intraperitoneally with the same volume of citrate buffer.

[0059] 5) According t...

Embodiment 2

[0065] Establishment of mouse corneal epithelial injury repair model:

[0066] 1) Select diabetic mice successfully induced in Example 1 and normal mice of the same age, and record blood glucose and body weight; for WT and miR-21KO diabetic mice, select mice with similar blood glucose and body weight for the experiment.

[0067] 2) General anesthesia for mice: extract 0.3ml of the prepared anesthetic, and inject intraperitoneally into the left lower abdomen of the mice.

[0068] 3) The right eye is the experimental eye, and the left eye does not undergo any treatment. After the mouse is anesthetized, the beard and eyelashes are cut off with the corneosclera, and the part around the experimental eye is disinfected with 0.5% Aner's iodine skin disinfectant, which is dripped into the conjunctival sac Topical anesthesia was performed with 1 drop of Alcaine eye drops.

[0069] 4) Use a 2.5mm diameter trephine to gently press and rotate the center of the mouse cornea to leave an in...

Embodiment 3

[0075] Nerve staining of whole mouse corneal smear

[0076] 1) Take miR-21KO normal mice, WT normal mice, WT diabetic mouse model (DMWT) and miR-21KO diabetic mouse model (DM miR-21KO) as the experimental objects, and kill the mice by conventional methods, and group them according to The eyeballs were taken out and put into EP tubes filled with Zamboni's fixative solution, and fixed on ice for 1 hour.

[0077] 2) Cut the corneal tissue. Note that during the cutting process, the fixative solution should completely submerge the eyeball, with the scleral limbus 0.5mm, try to remove excess iris, and continue to fix on ice for 1 hour (24-well plate, rinse with a 1ml gun when transferring the cornea, To prevent accumulation of endothelial deposits); all the front half of the eyeball can be cut off together and put into the fixative solution, and then the iris is cleaned one by one (to avoid corneal shrinkage, and the iris is easy to clean).

[0078] 3) Wash the cornea 3 times with ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides application of a reagent for promoting miR-21 expression in preparation of a medicine for preventing and / or treating diabetic keratopathy, and belongs to the technical field of biological medicines. A corneal epithelium injury model is established by using a type I diabetic mouse, miR-21agomir and NCagomir are injected under the conjunctiva, and a corneal fluorescein sodium staining result shows that in-vivo increase of miR-21 can promote corneal epithelium injury repair of the diabetic mouse. A whole corneal beta-tubulin specific staining result in 7 days after corneal epithelium is scraped shows that the density of corneal central and peripheral nerve plexus of a miR-21agomir group is obviously higher than that of a control group. Regeneration of corneal peripheral nerves of diabetic mice can be promoted by increasing miR-21 in vivo. Therefore, the invention provides the application of the miR-21 or the reagent for promoting miR-21 expression in the preparation of the medicine for preventing and / or treating the diabetic keratopathy.

Description

technical field [0001] The invention belongs to the technical field of biopharmaceuticals, and in particular relates to the application of a reagent for promoting miR-21 expression in the preparation of medicines for preventing and / or treating diabetic keratopathy. Background technique [0002] Diabetes mellitus is a chronic metabolic disease caused by insufficient insulin secretion or insufficient insulin utilization. It is one of the most common systemic diseases worldwide, and its incidence is increasing year by year. Diabetic eye complications are potentially vision-threatening diseases, and about 40% to 70% of diabetic patients will have changes in the corneal epithelium (keratopathy) and the subbasal nerve of the cornea (neuropathy). [0003] Corneal epithelium is an important ocular surface defense system, which provides physical and immune barriers to external organic and inorganic substances. When the glucose content in aqueous humor is too high for a long time, a s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/713A61P3/10A61P27/02C12N15/113
CPCA61K31/713A61K9/0019A61P27/02A61P3/10C12N15/113C12N2320/30
Inventor 阮庆国王婷冯莉娟王卓亚刘芮伶孙吉君
Owner 山东第一医科大学附属青岛眼科医院